Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-Microbiome Study
Top Cited Papers
Open Access
Abstract
Background: The gut microbiota has been linked to non-communicable diseases, including chronic kidney disease (CKD). However, the relationships between gut microbiome composition changes, uraemic toxins (UTs) accumulation, and diet on CKD severity and progression remain underexplored. Objective: To characterise relationships between gut microbiome composition and functionality, UTs diet, and CKD severity and progression, as well as assess microbial contributions to UTs accumulation through mice faecal microbiota transplantation (FMT). Design: This study profiled the gut microbiome of 240 non-dialysis patients with CKD (CKD-REIN cohort) using shotgun metagenomics, with follow-up in 103 patients after 3 years, with comparisons with healthy volunteers from the Milieu Intérieur cohort. A multiomics approach identifies features associated with CKD severity (and progression), with validation in an independent Belgian cohort. Experimental models used FMT to test CKD gut microbiome effects on UTs and kidney fibrosis. Changes in gut microbiome over time were evaluated, and the impact of diet on these changes was assessed. Results: Compared with matched healthy controls, patients with CKD exhibited gut microbiota alteration, with enrichment of UT precursor-producing species. Patients with severe CKD exhibited higher UT levels and greater enrichment of UT (precursor)-producing species in the microbiota than patients with moderate CKD. Over time, UT (precursor)-producing species increased, and a plant-based low protein diet appeared to mitigate these changes. FMT from patients with CKD to antibiotic-treated CKD model mice increased serum UT levels and exacerbated kidney fibrosis. Conclusions: This study highlights the role of the microbiome and UTs in CKD, suggesting a potential therapeutic target to slow disease progression.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-11-DPBS-0001, ANR-19-CE17-0023, ANR-IA-COH-2012/3731)
- Fonds Wetenschappelijk Onderzoek (G017815N)
This publication has 53 references indexed in Scilit:
- The Effect of Broccoli Glucoraphanin Supplementation on Ameliorating High‐Fat‐Diet‐Induced Obesity through the Gut Microbiome and Metabolome InterfaceMolecular Nutrition & Food Research, 2024
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseKidney International, 2024
- The probiotic L. casei Zhang slows the progression of acute and chronic kidney diseaseCell Metabolism, 2021
- Alterations of the Human Gut Microbiome in Chronic Kidney DiseaseAdvanced Science, 2020
- Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney diseaseKidney International, 2020
- Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet, 2020
- Noncontiguous finished genome sequence and description of Intestinimonas massiliensis sp. nov strain GD2T, the second Intestinimonas species cultured from the human gutMicrobiologyopen, 2018
- The Milieu Intérieur study — An integrative approach for study of human immunological varianceClinical Immunology, 2015
- Richness of human gut microbiome correlates with metabolic markersNature, 2013
- Chronic kidney disease alters intestinal microbial floraKidney International, 2013